Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers

Elizabeth C. Page, Elizabeth K. Bancroft, Mark N. Brook, Melissa Assel, Mona Hassan Al Battat, Sarah Thomas, Natalie Taylor, Anthony Chamberlain, Jennifer Pope, Holly Ni Raghallaigh, D. Gareth Evans, Jeanette Rothwell, Lovise Maehle, Eli Marie Grindedal, Paul James, Lyon Mascarenhas, Joanne McKinley, Lucy Side, Tessy Thomas, Christi van AsperenHans Vasen, Lambertus A. Kiemeney, Janneke Ringelberg, Thomas Dyrso Jensen, Palle J. S. Osther, Brian T. Helfand, Elena Genova, Rogier A. Oldenburg, Cezary Cybulski, Dominika Wokolorczyk, Kai-Ren Ong, Camilla Huber, Jimmy Lam, Louise Taylor, Monica Salinas, Lidia Feliubadalo, Jan C. Oosterwijk, Wendy van Zelst-Stamsm, Jackie Cook, Derek J. Rosario, Susan Domchek, Jacquelyn Powers, Saundra Buys, Karen O'Toole, Margreet G. E. M. Ausems, Rita K. Schmutzler, Kerstin Rhiem, Louise Izatt, Vishakha Tripathi, Apollonia T. J. M. Helderman van den Enden, IMPACT Study Collaborators

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)831-842
Number of pages12
JournalEuropean Urology
Volume76
Issue number6
DOIs
Publication statusPublished - Dec 2019

Keywords

  • BRCA1
  • BRCA2
  • Prostate-specific-antigen
  • Prostate cancer
  • Targeted prostate screening
  • CANCER MORTALITY
  • BREAST
  • TRIAL
  • MEN
  • PREDICTION
  • SURVIVAL
  • INCREASE
  • OVARIAN
  • ERSPC

Cite this

Page, E. C., Bancroft, E. K., Brook, M. N., Assel, M., Al Battat, M. H., Thomas, S., Taylor, N., Chamberlain, A., Pope, J., Raghallaigh, H. N., Evans, D. G., Rothwell, J., Maehle, L., Grindedal, E. M., James, P., Mascarenhas, L., McKinley, J., Side, L., Thomas, T., ... IMPACT Study Collaborators (2019). Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers. European Urology, 76(6), 831-842. https://doi.org/10.1016/j.eururo.2019.08.019